Kemp Dolliver
Stock Analyst at Brookline Capital Markets
(2.24)
# 3,090
Out of 4,520 analysts
64
Total ratings
35.4%
Success rate
1.4%
Average return
Main Sectors:
Stocks Rated by Kemp Dolliver
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TSXV: PINK Perimeter Medical Imaging AI, Inc. | Initiated Coverage: Buy | $1.54 | $0.31 | +404.92% | 1 | Jul 13, 2026 | |
| CLRB Cellectar Biosciences | Initiated Coverage: Buy | $15 | $2.51 | +497.61% | 1 | Jul 12, 2026 | |
| ICCM IceCure Medical | Maintained: Buy | $83 → $74 | $3.65 | +1,913.70% | 7 | Jun 17, 2026 | |
| LSTA Lisata Therapeutics | Downgraded: Hold | n/a | $3.60 | - | 2 | Jan 21, 2026 | |
| RNTX Rein Therapeutics | Downgraded: Hold | n/a | $0.8621 | - | 4 | Jan 21, 2026 | |
| VRCA Verrica Pharmaceuticals | Upgraded: Buy | $17 | $5.59 | +204.11% | 4 | Dec 17, 2025 | |
| MNPR Monopar Therapeutics | Maintained: Buy | $52 → $93 | $111.12 | -16.31% | 2 | Sep 25, 2025 | |
| IBIO iBio, Inc. | Reiterated: Buy | $1.6 | $1.38 | +15.94% | 3 | Sep 5, 2025 | |
| BIOX Bioceres Crop Solutions | Downgraded: Hold | $24 → $26 | $0.3501 | +7,326.45% | 8 | Aug 22, 2025 | |
| DARE Daré Bioscience | Maintained: Buy | $36 → $11 | $1.96 | +461.22% | 4 | Aug 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $18 | $4.43 | +306.32% | 1 | Jul 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $25 | $10.18 | n/a | 1 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $11 | $2.99 | n/a | 1 | Mar 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $2.74 | n/a | 2 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $150 → $26 | $2.80 | n/a | 2 | Feb 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $31 | $1.39 | n/a | 2 | Jan 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.9479 | n/a | 1 | Dec 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.061 | n/a | 1 | Dec 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $100 | $107.59 | n/a | 1 | Nov 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $25 → $30 | $2.87 | n/a | 2 | Oct 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $7 → $4.5 | $0.0251 | n/a | 6 | Sep 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $19 → $23 | $5.88 | n/a | 3 | Jul 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.000001 | n/a | 1 | May 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.0012 | n/a | 1 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.0001 | n/a | 1 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $6.60 | n/a | 1 | Dec 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8 | $4.27 | n/a | 1 | Oct 20, 2022 |
Perimeter Medical Imaging AI, Inc.
Jul 13, 2026
Initiated Coverage: Buy
Price Target: $1.54
Current: $0.31
Upside: +404.92%
Cellectar Biosciences
Jul 12, 2026
Initiated Coverage: Buy
Price Target: $15
Current: $2.51
Upside: +497.61%
IceCure Medical
Jun 17, 2026
Maintained: Buy
Price Target: $83 → $74
Current: $3.65
Upside: +1,913.70%
Lisata Therapeutics
Jan 21, 2026
Downgraded: Hold
Price Target: n/a
Current: $3.60
Upside: -
Rein Therapeutics
Jan 21, 2026
Downgraded: Hold
Price Target: n/a
Current: $0.8621
Upside: -
Verrica Pharmaceuticals
Dec 17, 2025
Upgraded: Buy
Price Target: $17
Current: $5.59
Upside: +204.11%
Monopar Therapeutics
Sep 25, 2025
Maintained: Buy
Price Target: $52 → $93
Current: $111.12
Upside: -16.31%
iBio, Inc.
Sep 5, 2025
Reiterated: Buy
Price Target: $1.6
Current: $1.38
Upside: +15.94%
Bioceres Crop Solutions
Aug 22, 2025
Downgraded: Hold
Price Target: $24 → $26
Current: $0.3501
Upside: +7,326.45%
Daré Bioscience
Aug 18, 2025
Maintained: Buy
Price Target: $36 → $11
Current: $1.96
Upside: +461.22%
Jul 21, 2025
Initiated Coverage: Buy
Price Target: $18
Current: $4.43
Upside: +306.32%
Jul 9, 2025
Initiated Coverage: Buy
Price Target: $25
Current: $10.18
Upside: n/a
Mar 10, 2025
Initiated Coverage: Buy
Price Target: $11
Current: $2.99
Upside: n/a
Nov 15, 2024
Downgraded: Hold
Price Target: n/a
Current: $2.74
Upside: n/a
Feb 14, 2024
Maintained: Buy
Price Target: $150 → $26
Current: $2.80
Upside: n/a
Jan 24, 2024
Upgraded: Buy
Price Target: $31
Current: $1.39
Upside: n/a
Dec 19, 2023
Downgraded: Hold
Price Target: n/a
Current: $0.9479
Upside: n/a
Dec 7, 2023
Downgraded: Hold
Price Target: n/a
Current: $0.061
Upside: n/a
Nov 30, 2023
Initiated Coverage: Buy
Price Target: $100
Current: $107.59
Upside: n/a
Oct 31, 2023
Upgraded: Buy
Price Target: $25 → $30
Current: $2.87
Upside: n/a
Sep 5, 2023
Downgraded: Hold
Price Target: $7 → $4.5
Current: $0.0251
Upside: n/a
Jul 11, 2023
Initiated Coverage: Buy
Price Target: $19 → $23
Current: $5.88
Upside: n/a
May 25, 2023
Downgraded: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
May 1, 2023
Downgraded: Hold
Price Target: n/a
Current: $0.0012
Upside: n/a
Jan 6, 2023
Downgraded: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Dec 16, 2022
Reiterated: Buy
Price Target: $13
Current: $6.60
Upside: n/a
Oct 20, 2022
Initiated Coverage: Buy
Price Target: $8
Current: $4.27
Upside: n/a